The Productivity Breakthrough: How Ever After Foods and Roslin Technologies are Redefining Cultivated Meat

In a milestone development for the alternative protein sector, two leading food-tech innovators—Israel-based Ever After Foods (EAF) and Scotland’s Roslin Technologies—have announced a breakthrough in the production of cultivated meat. By integrating their respective proprietary platforms, the companies have successfully produced structured cultivated meat tissue that demonstrates significantly higher protein concentrations and record-breaking levels of productivity.

This collaboration marks a departure from the industry’s decade-long focus on mere cell expansion, shifting the spotlight toward the efficiency of converting cellular growth into edible, high-quality tissue. The results of this partnership offer a promising pathway to resolving the "economic viability" dilemma that has historically hindered the transition of lab-grown meat from small-scale pilot projects to industrial-scale commercial reality.

The Core Innovation: Merging Platforms for Superior Yields

For years, the cultivated meat industry has been locked in a race to perfect stirred-tank bioreactor technology—the standard for growing cells in liquid suspension. However, the limitation of this approach is that it excels at producing cell mass but struggles to create the structured, complex tissues required for consumer-grade meat products like steaks or fillets.

Ever After Foods, a joint venture between cellular agriculture giant Pluri and the Tnuva Group, brought its advanced Edible Packed-Bed (EPB) production system and its "PlantriX" scaffold technology to the table. When combined with Roslin Technologies’ advanced porcine pluripotent stem cells, the results were transformative.

The partnership achieved a staggering 19-fold increase in cultivated protein and dry biomass productivity, alongside an 11-fold increase in wet biomass productivity, when measured against traditional stirred-tank benchmarks. By facilitating cell growth directly on an edible scaffold, the team effectively bypassed several downstream processing stages, such as complex cell harvesting, which typically add cost and time to the production cycle.

Chronology: From Concept to Commercial Validation

The roadmap to this breakthrough was defined by a systematic integration of two distinct technological philosophies:

Phase 1: Cell Platform Optimization (Roslin Technologies)

Roslin Technologies, a spinout from the University of Edinburgh, has long focused on the upstream development of animal cell lines. Their porcine pluripotent stem cells were chosen for this project due to their indefinite replication potential, genetic stability, and ability to differentiate into any tissue type. These cells were grown in suspension as multicellular aggregates, utilizing serum-free and animal-component-free media—a critical requirement for ethical and regulatory compliance.

Phase 2: Structural Integration (Ever After Foods)

Once the cell aggregates reached the desired state, they were mechanically dissociated and introduced into the EAF EPB bioreactor. This system is designed to mimic the natural biological environment of animal cells. Inside the bioreactor, the cells attached directly to the PlantriX scaffold.

Phase 3: The Productivity Milestone

Over a nine-day period, the cells demonstrated an extraordinary growth rate, achieving a density of 150 million cells per milliliter—a 62-fold increase. The efficiency was not just in the volume of cells, but in the quality of the output: a fourfold increase in protein and dry biomass yield per cell compared to industry standards.

Supporting Data: By the Numbers

The metrics released by EAF and Roslin provide a granular look at the efficiency gains:

• Cell Density: The combined system reached 150 million cells per ml, a 62-fold increase over the initial state.
• Volumetric Productivity: The platform produced 326g of wet biomass, 57g of dry biomass, and 40g of cultivated protein per litre.
• Scaffold Impact: The edible scaffold accounted for less than 2% of the final product’s weight, ensuring that the vast majority of the harvested product was high-quality, cultivated biomass.
• Performance Benchmarking: The system achieved a cell density five times higher than conventional stirred-tank suspension benchmarks.

These figures are not just laboratory curiosities; they represent the potential for a significant reduction in the infrastructure required to produce a single kilogram of meat. With higher output per unit of bioreactor volume, companies can theoretically produce more product with less steel, less electricity, and lower operational expenditures.

Official Perspectives: Industry Leaders Weigh In

Eyal Rosenthal, CEO of Ever After Foods, emphasizes that the primary goal of this partnership is to shift the industry from "innovation" to "industrialization."

"Manufacturing productivity is one of the biggest factors determining whether cultivated meat can become economically viable," Rosenthal explained in a recent briefing. "Higher output from the same cultivation volume means potentially less equipment, infrastructure, and operating cost per kilogram of product. Our technology also produces structured biomass directly on an edible scaffold, reducing the need for separate cell-harvesting and downstream processing steps."

Ernst van Orsouw, CEO of Roslin Technologies, underscored the importance of modularity in the sector. "These results demonstrate the versatility of our porcine pluripotent stem cells across suspension expansion and EAF’s tissue-production environment," said van Orsouw. "The collaboration provides an encouraging example of how complementary technologies can be integrated to address key scale-up challenges."

Implications: The Path to Economic Parity

The implications of this breakthrough for the cultivated meat market are profound. For over a decade, critics have pointed to the high cost of media and the prohibitive capital expenditure (CapEx) of building large-scale bioreactor farms as the two primary barriers to market entry.

1. Capital and Operational Efficiency

Techno-economic modeling conducted by EAF suggests that their approach could lead to substantial reductions in both capital investment and production costs compared to traditional methods. By increasing the density of the product within the reactor, the cost per kilogram drops, moving the price point closer to that of conventional livestock products.

2. Commercial Strategy

EAF is positioning itself not as a direct-to-consumer meat brand, but as a manufacturing technology provider. Their strategy involves supplying the EPB platform to cultivated meat producers, essentially acting as the "Intel Inside" of the alternative protein movement. To that end, they have already partnered with industrial powerhouse Bühler to develop a 200-litre modular production system, with the next step being industrial-scale validation.

3. Diversification into New Verticals

Beyond traditional pork or beef, the flexibility of the EAF and Roslin platform extends to other categories. Following EAF’s acquisition of Fishway, the company is actively exploring cultivated seafood. Additionally, they have identified pet food as a potential "early adopter" market, where the requirements for consumer acceptance and regulatory hurdles are slightly different from those of human-grade meat products.

4. Regulatory Readiness

While the technology is advancing rapidly, the companies remain cautious regarding the regulatory landscape. They are currently preparing for filings in key markets including Singapore, Israel, and the United States. Rosenthal notes that because they are a technology provider, the specific regulatory path will depend on the partner company’s product and the target market.

Conclusion: A New Era for Cultivated Meat

The partnership between Ever After Foods and Roslin Technologies represents a pivotal shift in the cultivated meat narrative. By moving beyond the "density race" and successfully integrating scaffold-based structural growth with high-efficiency cell platforms, they have provided a blueprint for how the industry can overcome its biggest hurdles.

As they move toward commercial validation and industrial-scale deployment, the sector will be watching closely. If the productivity gains observed in the lab can be replicated at the 200-litre modular scale and beyond, the dream of affordable, sustainable, and animal-free meat may finally be within striking distance of the global consumer market. The focus has moved from "can we grow it?" to "how efficiently can we produce it?"—and for the first time in a long time, the answer is looking increasingly optimistic.